[On the behavior of the so-called leucine aminopeptidase (LAP) in the serum during the application of various substrates].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001660:Biliary Tract Diseases / Q000201:enzymology*; D002779:Cholestasis / Q000201:enzymology*; D005260:Female; D005998:Glycine / Q000378:metabolism; D006801:Humans; D007930:Leucine / Q000378:metabolism; D007931:Leucyl Aminopeptidase / Q000097:blood*; D008107:Liver Diseases / Q000201:enzymology*; D008113:Liver Neoplasms / Q000201:enzymology*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000201:enzymology*; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000201:enzymology*; D051381:Rats
D001219:Aspartate Aminotransferases; D007931:Leucyl Aminopeptidase; D007930:Leucine; D005998:Glycine
Uber das Verhalten der sog. Leucinaminopepidase (LAP) im Serum unter Verwendung verschiedener Substrate.